Ben Sahacic

Ben Sahacic has extensive experience in supply chain management, with a focus on clinical and commercial operations. Ben currently holds the position of Vice President, Supply Chain at Blueprint Medicines, where they lead a global team responsible for supply chain strategy, planning, and execution. Ben is also responsible for overseeing international supply chain operations in multiple regions. Prior to joining Blueprint Medicines, Sahacic served as Senior Director Supply Chain at Blueprint Medicines, where they developed and optimized the company's end-to-end supply chain vision and strategies. Ben also led negotiations for various agreements with third-party logistics companies and commercial partners. Before that, Sahacic worked at Lonza as Director Commercial Development, where they were responsible for developing and executing strategic plans to grow the company's presence in the solid dosage forms market. Ben also managed the portfolio of solid dosage forms products and oversaw proposal generation and client pricing. Sahacic also held leadership positions at Capsugel (acquired by Lonza) as Vice President, Project Management & Supply Chain, and at ARIAD Pharmaceuticals and Shionogi Pharma Inc. in various supply chain roles. Ben started their career at Bristol-Myers Squibb as a Supply Chain Manager. Throughout their career, Sahacic has demonstrated expertise in strategic sourcing, contract negotiation, and regulatory compliance, with a track record of leading successful commercial launches and managing global supply chain operations.

Ben Sahacic earned their MBA in Supply Chain Management from Syracuse University - Martin J. Whitman School of Management from 2002 to 2004. Prior to that, they obtained a BA in Economics and Financial Accounting from the University of Sarajevo between 1996 and 2001. Additionally, they have some involvement with Harvard Business School, but no specific degree or field of study is provided.